Use of Nirsevimab for Respiratory Syncytial Virus (RSV) prevention in India: current status and way forward
Clinical Epidemiology and Global Health · 2026-05 · 39 · 102371
DOI: 10.1016/j.cegh.2026.102371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Epidemiology and Global Health, 2026-05. Verfasst von Nonita Dudeja und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dudeja, N., Dudeja, S., Mohapatra, A., & Anand, P. (2026). Use of Nirsevimab for Respiratory Syncytial Virus (RSV) prevention in India: current status and way forward. Clinical Epidemiology and Global Health, 39, 102371. https://doi.org/10.1016/j.cegh.2026.102371
Vancouver
Dudeja N, Dudeja S, Mohapatra A, Anand P. Use of Nirsevimab for Respiratory Syncytial Virus (RSV) prevention in India: current status and way forward. Clinical Epidemiology and Global Health. 2026;39:102371. doi:10.1016/j.cegh.2026.102371
BibTeX
@article{Dudeja2026,
author = {Dudeja, Nonita and Dudeja, Sankalp and Mohapatra, Archisman and Anand, Pratima},
title = {Use of Nirsevimab for Respiratory Syncytial Virus (RSV) prevention in India: current status and way forward},
journal = {Clinical Epidemiology and Global Health},
year = {2026},
volume = {39},
pages = {102371},
doi = {10.1016/j.cegh.2026.102371}
}
EUVIMED